Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2651 |
|
| Actual shortage: | 257 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2385 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42632 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42635 |
| NOVO-PROFEN | 400MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42644 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42651 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43116 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43122 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43126 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43129 |
| TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43132 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43135 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43138 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43141 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43171 |
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43174 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50023 |
| TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50026 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50029 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2018-06-15 | 2019-05-28 | 52485 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-06-15 | 2018-11-08 | 52488 |
| ACT ETIDROCAL | 400MG 500MG | TABLET | Actual shortage | 2018-08-01 | 2019-02-21 | 57207 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |